Related Experiment Video
Updated: Aug 27, 2025
05:46
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
5.2K
Novel Proline Derivatives for Treating COVID-19.
Surya K De1,2
1Conju-probe, San Diego, California, USA.
Current Medicinal Chemistry
|September 26, 2022
Summary
This patent describes novel proline-like compounds that act as peptidomimetic inhibitors of the main protease, similar to Paxlovid, for potential COVID-19 treatment.
Area of Science:
- Medicinal Chemistry
- Virology
- Drug Discovery
Background:
- COVID-19 is a highly contagious viral disease.
- Paxlovid (Nirmatrelvir/Ritonavir) received FDA emergency use authorization for COVID-19 treatment.
- Nirmatrelvir, a key component of Paxlovid, is a proline derivative and a protease inhibitor.
Purpose of the Study:
- To describe novel proline-like compounds.
- To detail the preparation and pharmaceutical use of these compounds.
- To explore their application in treating viral infections, including COVID-19.
Main Methods:
- Synthesis and characterization of proline-like compounds.
- Evaluation of peptidomimetic properties.
- Formulation of pharmaceutical compositions.
Main Results:
- The patent discloses specific proline-like compounds.
- Methods for their preparation are provided.
- Potential therapeutic applications are outlined.
Conclusions:
- The described compounds represent a new class of potential antiviral agents.
- These compounds may offer alternative or complementary treatments for COVID-19.
- Further research is warranted to evaluate their efficacy and safety.
Related Concept Videos
02:50Conjugated Proteins
18.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
247
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
247
01:05Single Nucleotide Polymorphisms-SNPs
15.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.6K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
220
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
220
01:19Antiasthma Drugs: Leukotriene Modifiers
417
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
417